Inventor · disambiguated record
Gregg Timony
Also filed as: TIMONY GREGG · TIMONY GREGG A · TIMONY GREGG ALAN
6 granted patents·7 pending applications·23 citations·filing 2004–2024
79Inventor score
Files withABBVIE INC4CONFORMA THERAPEUTICS CORP4RECEPTOS INC3CELGENE INT II SARL1CELGENE INT II SÀRL1
Top patents by PatentIndex Score
13 records- 0189US9388147B2Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesisRECEPTOS INC·Filed 2015·Granted Jul 12, 2016·9 cites·36 claims
- 0288US8362048B2Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesisRECEPTOS INC·Filed 2010·Granted Jan 29, 2013·10 cites·24 claims
- 0382US11390669B2Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodiesABBVIE INC·Filed 2017·Granted Jul 19, 2022·2 cites·27 claims
- 0482US2024425582A1Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodiesABBVIE INC·Filed 2024·Application pending·0 cites
- 0580US12129294B2Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodiesABBVIE INC·Filed 2023·Granted Oct 29, 2024·0 cites·15 claims
- 0680US10239846B2Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesisCELGENE INT II SARL·Filed 2017·Granted Mar 26, 2019·2 cites·10 claims
- 0777US12122826B2Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodiesABBVIE INC·Filed 2022·Granted Oct 22, 2024·0 cites·27 claims
- 0857US2013231326A1Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesisRECEPTOS INC·Filed 2013·Application pending·0 cites
- 0957US2006067953A1Oral pharmaceutical formulations and methods for producing and using sameCONFORMA THERAPEUTICS CORP·Filed 2004·Application pending·0 cites
- 1056US2010063020A1Oral pharmaceutical formulations and methods for producing and using sameCONFORMA THERAPEUTICS CORP·Filed 2009·Application pending·0 cites
- 1155US2009238880A1Phospholipid-based pharmaceutical formulations and methods for producing and using sameCONFORMA THERAPEUTICS CORP·Filed 2009·Application pending·0 cites
- 1253US2017165236A1Selective sphingosine 1 phosphate receptor modulators and combination therapy therewithCELGENE INT II SÀRL·Filed 2014·Application pending·0 cites
- 1348US2006228405A1Phospholipid-based pharmaceutical formulations and methods for producing and using sameCONFORMA THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →